Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications

被引:82
作者
Anahi Valdes-Rives, Silvia [1 ]
Casique-Aguirre, Diana [2 ]
German-Castelan, Liliana [1 ]
Velasco-Velazquez, Marco A. [2 ,3 ]
Gonzalez-Arenas, Aliesha [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dep Med Genom & Toxicol Ambiental, Ciudad De Mexico, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Med, Dept Farmacol, Ciudad De Mexico, Mexico
[3] Univ Nacl Autonoma Mexico, Fac Med, Unidad Perifer Invest Biomed Translac, ISSSTE CMN Noviembre 20, Ciudad De Mexico, Mexico
关键词
NF-KAPPA-B; GLIOMA STEM-CELLS; SMALL-MOLECULE INHIBITOR; X-LINKED INHIBITOR; BCL-2; FAMILY; GROWTH-FACTOR; PTEN GENE; FACTOR RECEPTOR; EXPRESSION; MULTIFORME;
D O I
10.1155/2017/7403747
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Glioblastoma multiforme (GBM) is the most hostile type of brain cancer. Its aggressiveness is due to increased invasion, migration, proliferation, angiogenesis, and a decreased apoptosis. In this review, we discuss the role of key regulators of apoptosis in GBM and glioblastoma stem cells. Given their importance in the etiology and pathogenesis of GBM, these signaling molecules may represent potential therapeutic targets.
引用
收藏
页数:12
相关论文
共 50 条
[31]   Oncogenic roles of long non-coding RNAs in essential glioblastoma signaling pathways [J].
Lashkarboloki, Mina ;
Jahanbakhshi, Amin ;
Mowla, Seyed Javad ;
Bjeije, Hassan ;
Soltani, Bahram M. .
JOURNAL OF NEUROGENETICS, 2024, 38 (03) :62-78
[32]   Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotype [J].
Henderson, C ;
Brancolini, C .
DRUG RESISTANCE UPDATES, 2003, 6 (05) :247-256
[33]   Widespread Deregulation of Phosphorylation-Based Signaling Pathways in Multiple Myeloma Cells: Opportunities for Therapeutic intervention [J].
Fuhler, Gwenny Manel ;
Diks, Sander Henricus ;
Peppelenbosch, Maikel Petrus ;
Kerr, William Garrow .
MOLECULAR MEDICINE, 2011, 17 (7-8) :790-798
[34]   Osteoarthritis: pathogenic signaling pathways and therapeutic targets [J].
Yao, Qing ;
Wu, Xiaohao ;
Tao, Chu ;
Gong, Weiyuan ;
Chen, Mingjue ;
Qu, Minghao ;
Zhong, Yiming ;
He, Tailin ;
Chen, Sheng ;
Xiao, Guozhi .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
[35]   Therapeutic targeting of signaling pathways in muscular dystrophy [J].
Bhatnagar, Shephali ;
Kumar, Ashok .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (02) :155-166
[36]   Signaling pathways and therapeutic interventions in gastric cancer [J].
Lei, Zi-Ning ;
Teng, Qiu-Xu ;
Tian, Qin ;
Chen, Wei ;
Xie, Yuhao ;
Wu, Kaiming ;
Zeng, Qianlin ;
Zeng, Leli ;
Pan, Yihang ;
Chen, Zhe-Sheng ;
He, Yulong .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[37]   Immunometabolism: signaling pathways, homeostasis, and therapeutic targets [J].
Xu, Rongrong ;
He, Xiaobo ;
Xu, Jia ;
Yu, Ganjun ;
Wu, Yanfeng .
MEDCOMM, 2024, 5 (11)
[38]   Hepatocellular carcinoma: signaling pathways and therapeutic advances [J].
Zheng, Jiaojiao ;
Wang, Siying ;
Xia, Lei ;
Sun, Zhen ;
Chan, Kui Ming ;
Bernards, Rene ;
Qin, Wenxin ;
Chen, Jinhong ;
Xia, Qiang ;
Jin, Haojie .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
[39]   Signaling pathways in lymphoma: pathogenesis and therapeutic targets [J].
Arita, Adriana ;
McFarland, Daniel C. ;
Myklebust, June H. ;
Parekh, Samir ;
Petersen, Bruce ;
Gabrilove, Janice ;
Brody, Joshua D. .
FUTURE ONCOLOGY, 2013, 9 (10) :1549-1571
[40]   Therapeutic Implications of Targeting YY1 in Glioblastoma [J].
Navasardyan, Inesa ;
Zaravinos, Apostolos ;
Bonavida, Benjamin .
CANCERS, 2024, 16 (11)